Menu

Maps for Disease

A collaboration between Doctors Without Borders, the Red Cross, and other organizations aims to map developing cities across the globe to improve disease response efforts.

Nov 10, 2014
Jef Akst

FLICKR, SUE CLARKIn 2010, Ivan Gayton of Doctors Without Borders responded to call from a nun in Haiti, who described how her town was suffering from an outbreak of cholera following a massive earthquake. But finding her wasn’t easy, Gayton recounted to The Guardian, in large part because there was no decent map of the area. “Much of the time [the address given] may as well be random syllables,” Gayton said. “If there was a point source for cholera in Haiti, we wouldn’t have known where it was. We needed a map—to be able to correlate the alerts we hear and our patient origins to something on the ground.”

Enter the Missing Maps project, a collaborative effort launched this month by the Humanitarian OpenStreetMap Team (HOT),  Doctors Without Borders, the American Red Cross, and the British Red Cross that aims to create free digital maps for every village and town on the planet. The Guardian called it “nothing less than a human genome project for the world’s cities.”

The method for developing the new maps was created by the HOT, and involves volunteers around the world. Anyone with an internet connection can use a simple point-and-click tool to note the locations of landmarks, such as roads, parks, and buildings on satellite images that have been entered into free mapping software called OpenStreetMap. The satellite images are then removed and the rudimentary maps printed, and more local volunteers head out to verify the information and add the names of streets and buildings. The marked up maps are then shared with the Missing Maps headquarters in London, where even more volunteers input the data into the OpenStreeMap program.

The project has already produced a new digital map of Lubumbashi, a city in the Democratic Republic of Congo, and Doctors Without Borders and the Red Cross have begun recruiting volunteers to help map Ebola-affected regions. The project aims to map the rest of the underdeveloped world in the next two years, according to The Guardian. And because the maps will all be open source, anyone can use and even improve them. “It will be illegal for anyone to charge anyone to use them—meaning local people will have total access to them, not just to look at, but to edit and develop,” Missing Maps coordinator Pete Masters told the publication.

“Finally, I can give volunteers something to do that isn’t just giving money,” Gayton added. “With Missing Maps, they can actually participate in real, genuine fieldwork. That’s huge.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.